Live Breaking News & Updates on கைசர் நிரந்தர ஆரோக்கியம் ஆராய்ச்சி நிறுவனம்

As part of a phase 1 clinical trial of a variant-specific COVID-19 vaccine developed by Moderna, pharmacist Sue Lasicka gives a shot of the vaccine candidate to volunteer Suzanne Uvelli-Spencer, MD, on April 1, 2021, at Kaiser Permanente Washington Health Research Institute in Seattle.
Credit:
Courtesy of Jonathan Rabinovitz
Seattle-based clinical trial tweaks mRNA vaccines to fight Covid variants
Apr 08, 2021
Researchers are testing a new Covid-19 vaccine. Part of the clinical trial is taking place here in Seattle. The trial will tweak the Moderna vaccine to fight one variant of the Covid virus, B1351. That s the variant first discovered in South Africa.
This interview has been edited for clarity. ....

South Africa , Suzanne Uvelli Spencer , Lisa Jackson , Jonathan Rabinovitz , Paige Browning , Kaiser Permanente Health Research Institute , Sue Lasicka , Kaiser Permanente , Health Research , லிசா ஜாக்சன் , பைஜ் பிரவுனிங் , கைசர் நிரந்தர ஆரோக்கியம் ஆராய்ச்சி நிறுவனம் , கைசர் நிரந்தர , ஆரோக்கியம் ஆராய்ச்சி ,